Odyssey Therapeutics, Inc. news ODTX
Plain-English coverage of this company’s material 8-K filings — generated from the primary source the moment they file.
← back to Odyssey Therapeutics, Inc.-
High Positive
Odyssey Therapeutics (ODTX) Reports OD-001 POC, Raises $464M
Clinical-stage biotech achieves proof-of-concept for ulcerative colitis drug and closes IPO plus private placement.